Sample6 Secures $11 Million in Series B Financing to Support Commercialization of Company’s Food Safety Products

October 11, 2013

Boston, Mass. – Sample6, a company focused on applying biotechnology to advance food safety, announced today that it has secured a $11 million Series B financing round led by Canaan Partners. Joining the round are Cultivian Sandbox, a fund which invests in emerging technologies in the food and agriculture industry, and Series A lead investor Flybridge Capital Partners.  In addition, the company noted that Stephen Bloch, MD, General Partner of Canaan Partners, has joined its Board of Directors while Peter Farina, PhD, Executive in Residence for Canaan Partners, will join its Scientific Advisory Board.

The funds will be used to commercialize Sample6’s first products, Sample6 DETECT/L and Sample6 CONTROL, which are designed to enable in-plant, in-shift pathogen detection in food processing environments. Sample6 DETECT/L is the company’s first diagnostic assay and is designed to identify Listeria contamination. Sample6 CONTROL is the company’s software platform, which is used by food companies to plan, execute, remediate and analyze food safety programs.

Current technologies to identify and remediate bacterial contamination can take several days to yield results, putting the safety of the food supply at risk. Sample6 provides the world’s first synthetic-biology based bacteria diagnostic system that allows for enrichment-free detection and subsequent remediation of pathogens in less than eight hours, or a single work shift. The tests are able to detect levels of bacteria as low as one colony forming unit in one milliliter of liquid in only a few hours. The company’s proprietary Bioillumination Platform™ allows for detection through engineered bioparticles, or biosensors, that target and illuminate contaminating bacteria.

“We are poised to bring to market our diagnostic and data analytics solutions that have the power to radically change, at first, the food industry’s safety processes – taking a detection and remediation process that takes days down to one that takes hours,” noted Tim Curran, CEO of Sample6. “Backing from Canaan and Cultivian will allow us to bring our revolutionary products to the U.S. food market and also explore other markets where bacterial contamination is an issue such as hospitals and clinics.”

“On behalf of the Massachusetts Life Sciences Center (MLSC), congratulations to Sample6 on the close of its Series B round of financing,” said Susan Windham-Bannister, PhD, President & CEO of the MLSC, the quasi-public agency tasked with implementing the state’s 10-year, $1-billion Life Sciences Initiative. “As a 2012 Accelerator Loan recipient, Sample6 is highly leveraging the state’s funding to reach the ultimate launch of its pathogen-detection platform.”

“Sample6 has the potential to dramatically improve food safety by simplifying and accelerating how we test for Listeria, Salmonella and E. coli.   Sample6’s team is determined to change the way the industry tests for and detects harmful bacteria in our food supply,” said Dr. Bloch.

Both the Sample6 DETECT and the Sample6 CONTROL are expected to be available in the first half of 2014.

About Sample6

Sample6 is making food safer by delivering two powerful tools to the food industry, Sample6 DETECT and Sample6 CONTROL.  Sample6 DETECT is an on-site in-shift pathogen diagnostic.  This advancement paired with powerful analytics from Sample6 CONTROL will shift food safety from reaction to prevention, which is the primary goal of the FSMA and HAACP initiatives in the US.  Food processors from meat, dairy, produce, dry goods have already partnered with Sample6 in order to integrate these revolutionary products into their plants.  For more information, please visit www.sample6.com

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.